Acute Lymphobkastic Leukemia Recruiting Phase 4 Trials for Prednisone (DB00635)

IndicationStatusPhase
DBCOND0068117 (Acute Lymphobkastic Leukemia)Recruiting4
clinicaltrials.gov IdentifierTitlePurposeDrugs